{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:10:19Z","timestamp":1772187019047,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12905-018-0559-3","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T12:50:20Z","timestamp":1526907020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Performance of OncoE6 cervical test with collection methods enabling self-sampling"],"prefix":"10.1186","volume":"18","author":[{"given":"Amrei","family":"Krings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"D\u00fcckelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Gollrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Wiegerinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas M.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"559_CR1","unstructured":"Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, Bosch F, de Sanjos\u00e9 S. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 27 July 2017. http:\/\/www.hpvcentre.net\/statistics\/reports\/XWX.pdf . Accessed 13 May 2018."},{"key":"559_CR2","unstructured":"International Agency for Research on Cancer. Biological agents. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100B."},{"issue":"1","key":"559_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"11","key":"559_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"key":"559_CR5","unstructured":"World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: World Health Organization; 2013. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK195239\/ . Accessed 15 May 2018."},{"issue":"Suppl 7","key":"559_CR6","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","volume":"31","author":"FX Bosch","year":"2013","unstructured":"Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013;31(Suppl 7):H1\u201331.","journal-title":"Vaccine"},{"issue":"3","key":"559_CR7","doi-asserted-by":"publisher","first-page":"10473","DOI":"10.4238\/2015.September.8.8","volume":"14","author":"B Jiang","year":"2015","unstructured":"Jiang B, Xue M. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells. Genet Mol Res. 2015;14(3):10473\u201381.","journal-title":"Genet Mol Res"},{"issue":"5\u20136","key":"559_CR8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.mcp.2011.05.003","volume":"25","author":"M Schmitt","year":"2011","unstructured":"Schmitt M, Dalstein V, Waterboer T, Clavel C, Gissmann L, Pawlita M. The HPV16 transcriptome in cervical lesions of different grades. Mol Cell Probes. 2011;25(5\u20136):260\u20135.","journal-title":"Mol Cell Probes"},{"issue":"12","key":"559_CR9","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1128\/JCM.01315-10","volume":"48","author":"J Schweizer","year":"2010","unstructured":"Schweizer J, Lu PS, Mahoney CW, Berard-Bergery M, Ho M, Ramasamy V, Silver JE, Bisht A, Labiad Y, Peck RB, et al. Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer. J Clin Microbiol. 2010;48(12):4646\u20138.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"559_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1158\/1940-6207.CAPR-13-0091","volume":"6","author":"FH Zhao","year":"2013","unstructured":"Zhao FH, Jeronimo J, Qiao YL, Schweizer J, Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, et al. An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev Res (Phila). 2013;6(9):938\u201348.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"559_CR11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29026","volume":"136","author":"RP Bosgraaf","year":"2015","unstructured":"Bosgraaf RP, Verhoef VM, Massuger LF, Siebers AG, Bulten J, de Kuyper-de Ridder GM, Meijer CJ, Snijders PJ, Heideman DA, IntHout J, et al. Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening. Int J Cancer. 2015;136(3):646\u201355.","journal-title":"Int J Cancer"},{"issue":"3","key":"559_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ijc.25974","volume":"129","author":"PE Gravitt","year":"2011","unstructured":"Gravitt PE, Belinson JL, Salmeron J, Shah KV. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer. 2011;129(3):517\u201327.","journal-title":"Int J Cancer"},{"issue":"2","key":"559_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","volume":"15","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao FH, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15(2):172\u201383.","journal-title":"Lancet Oncol"},{"issue":"10","key":"559_CR14","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1128\/JCM.01026-11","volume":"49","author":"Y Delere","year":"2011","unstructured":"Delere Y, Schuster M, Vartazarowa E, Hansel T, Hagemann I, Borchardt S, Perlitz H, Schneider A, Reiter S, Kaufmann AM. Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years. J Clin Microbiol. 2011;49(10):3519\u201322.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"559_CR15","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1128\/JCM.02227-07","volume":"46","author":"M Schmitt","year":"2008","unstructured":"Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol. 2008;46(3):1050\u20139.","journal-title":"J Clin Microbiol"},{"key":"559_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2334-14-87","volume":"14","author":"Y Delere","year":"2014","unstructured":"Delere Y, Remschmidt C, Leuschner J, Schuster M, Fesenfeld M, Schneider A, Wichmann O, Kaufmann AM. Human papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis. 2014;14:87.","journal-title":"BMC Infect Dis"},{"key":"559_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13027-015-0010-4","volume":"10","author":"LM Boumba","year":"2015","unstructured":"Boumba LM, Assoumou SZ, Hilali L, Mambou JV, Moukassa D, Ennaji MM. Genetic variability in E6 and E7 oncogenes of human papillomavirus type 16 from Congolese cervical cancer isolates. Infect Agent Cancer. 2015;10:15.","journal-title":"Infect Agent Cancer"},{"issue":"1\u20132","key":"559_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","volume":"445","author":"RD Burk","year":"2013","unstructured":"Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology. 2013;445(1\u20132):232\u201343.","journal-title":"Virology"},{"issue":"4","key":"559_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jnci\/93.4.315","volume":"93","author":"A Hildesheim","year":"2001","unstructured":"Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001;93(4):315\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"559_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.virol.2010.10.039","volume":"410","author":"A Huertas-Salgado","year":"2011","unstructured":"Huertas-Salgado A, Martin-Gamez DC, Moreno P, Murillo R, Bravo MM, Villa L, Molano M. E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature. Virology. 2011;410(1):201\u201315.","journal-title":"Virology"},{"issue":"12","key":"559_CR21","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1007\/s00705-014-2199-8","volume":"159","author":"A Plesa","year":"2014","unstructured":"Plesa A, Anton G, Iancu IV, Diaconu CC, Huica I, Stanescu AD, Socolov D, Nistor E, Popa E, Stoian M, et al. Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients. Arch Virol. 2014;159(12):3305\u201320.","journal-title":"Arch Virol"},{"key":"559_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/1471-2334-13-378","volume":"13","author":"Z Qmichou","year":"2013","unstructured":"Qmichou Z, Khyatti M, Berraho M, Ennaji MM, Benbacer L, Nejjari C, Benjaafar N, Benider A, Attaleb M, El Mzibri M. Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women. BMC Infect Dis. 2013;13:378.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"559_CR23","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1128\/JVI.71.3.2463-2472.1997","volume":"71","author":"T Yamada","year":"1997","unstructured":"Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997;71(3):2463\u201372.","journal-title":"J Virol"},{"issue":"11","key":"559_CR24","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1002\/jmv.24043","volume":"86","author":"L Yang","year":"2014","unstructured":"Yang L, Yang H, Wu K, Shi X, Ma S, Sun Q. Prevalence of HPV and variation of HPV 16\/HPV 18 E6\/E7 genes in cervical cancer in women in South West China. J Med Virol. 2014;86(11):1926\u201336.","journal-title":"J Med Virol"},{"issue":"2","key":"559_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/jmv.24333","volume":"88","author":"Y Yang","year":"2016","unstructured":"Yang Y, Ren J, Zhang Q. Distribution of human papilloma virus type 16 E6\/E7 gene mutation in cervical precancer or cancer: a case control study in Guizhou Province, China. J Med Virol. 2016;88(2):345\u201350.","journal-title":"J Med Virol"},{"issue":"5","key":"559_CR26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/ijc.25144","volume":"127","author":"JL Belinson","year":"2010","unstructured":"Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, et al. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer. 2010;127(5):1151\u20137.","journal-title":"Int J Cancer"},{"issue":"6","key":"559_CR27","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/ijc.30807","volume":"141","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Dong L, Hu S, Feng R, Zhang X, Pan Q, Ma J, Zhang L, Zhao X, Sankaranarayanan R, et al. Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China. Int J Cancer. 2017;141(6):1110\u20139.","journal-title":"Int J Cancer"},{"issue":"2","key":"559_CR28","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2214-109X(14)70354-7","volume":"3","author":"S Arrossi","year":"2015","unstructured":"Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, Barletta P, Laudi R, Orellana L, team EMAS. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3(2):e85\u201394.","journal-title":"Lancet Glob Health"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-018-0559-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-018-0559-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-018-0559-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T22:09:10Z","timestamp":1720303750000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-018-0559-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1186\/s12905-018-0559-3","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was granted by Charit\u00e9 Universit\u00e4tsmedizin Berlin ethical review board (EA1\/168\/13) and patients gave their written consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"AK The authors declare that they have no competing interests.AMD The authors declare that they have no competing interests.LM The authors declare that they have no competing interests.JG The authors declare that they have no competing interests.MW is founder of Mysample Device Diagnostics B.V. and former of Delphi Bioscience, the company producing the self-sampling device Delphi Screener before acquisition by Rovers Medical Devices.JS is an employee and shareholder at Arbor Vita Corporation, producing the OncoE6 Cervical Test.AMK The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"68"}}